亚急性渐进性严重的Sjögren综合征的无毒感官神经病变
Tomohiro Fujioka1, Kimito Kondo1, Nobuo Kohara2
1Department of Neurology, Hokuto Hospital, Japan.
Internal medicine (Tokyo, Japan)
|November 5, 2023
概括
这一案例突出了一个罕见的呈现,即在一位老年妇女身上快速进展的性感官神经病变,最终被诊断为Sjögren综合征. 早期诊断和免疫疗法至关重要,但可能无法阻止疾病的进展.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 亚急性渐进性无氧性感官神经病变呈现出迅速发作的神经学缺陷.
- 肖格伦综合征是一种自身免疫性疾病,可以影响神经系统.
- 区分这种神经病变与其他疾病,如吉兰-巴雷综合征,对于适当的管理至关重要.
研究的目的:
- 报告一个快速进展的无氧性感官神经病变病例.
- 为了调查这种神经病变与Sjögren综合征之间的关联.
- 在这种特定的临床背景下评估免疫治疗的疗效.
主要方法:
- 一个79岁的女性患者的临床病例介绍.
- 详细的神经检查和症状进展跟踪.
- 神经传导研究以表征神经病变.
- 进行全面的诊断工作,以确定潜在原因,包括自身免疫标志物.
- 给药和免疫疗法反应的评估.
主要成果:
- 患者表现出亚急性,渐进的感觉症状,包括下肢麻木,步态障碍和异常感觉.
- 神经传导研究证实了纯粹的轴突类型感官多神经病变.
- 这名患者被诊断为Sjögren综合征的第二次触动性感官神经病变.
- 尽管进行了密集的免疫治疗,但疾病的进展并没有停止.
结论:
- 性感官神经病变可以呈现出快速恶化,模仿其他神经紧急情况.
- 在快速进展的神经病变的差异诊断中应考虑Sjögren综合征.
- 早期和全面的诊断对于及时干预至关重要.
- 虽然免疫疗法是适用的,但在这种特定情况下,其在阻止疾病进展方面的有效性可能是有限的,这凸显了需要进一步研究的需要.
更多相关视频
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
01:28Major Somatic Sensory Pathways
986
Sensory impulses related to touch, pressure, vibration, and proprioception from various body parts, such as the limbs, trunk, neck, and posterior head, travel to the cerebral cortex through the posterior column-medial lemniscus pathway. The pathway’s name derives from the two white-matter tracts that convey the impulses: the spinal cord's posterior column and the brainstem's medial lemniscus. First-order sensory neurons extend their axons into the spinal cord, forming the...
986
01:24Nephrotic Syndrome I : Introduction
8
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
8
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14
01:26Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
01:15Myasthenia Gravis: Diagnostic Tests
914
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
914